Şunu aradınız:: klinikali (Maltaca - İngilizce)

pataloġija klinikali
clinical pathology

dejta farmakodinamika klinikali
clinical pharmacodynamic data

effikaċja u sigurtà klinikali:
clinical efficacy and safety:

l-iżolazzjoni tal-coxiellaburnetii minn kampjun klinikali
isolation of coxiella burnetii from a clinical specimen,

l-informazzjoni klinikali msemmija f’anness 7,
the clinical data referred to in annex 7,

tagħrif mhux- klinikali dwar it- tossiċità ġenerali ta 'mitotane huwa limitat.
non-clinical data on the general toxicity of mitotane is limited.

stampa klinikali kompatibbli ma' waħda mill-għamliet differenti tat-tularemja:
clinical picture compatible with one of the different forms of tularaemia:

l- użu ta ’ dawn il- mediċini flimkien ma żieditx il - benefiċċju klinikali.
this combination has not demonstrated increased clinical benefit.

l- inċidenza ta ’ dawn l- episodji fi studji klinikali kienu > 10%.
the incidence of these events in clinical studies was > 10%.

imma, ma kienet osservata l- ebda assoċjazzjoni mar- riżultat klinikali jew episodju avvers fi studji klinikali.
however, no association with clinical outcome or adverse event could be observed in clinical studies.

wirja tas-c. burnetii f'kampjun klinikali fil-kxif ta' antiġen jew aċidu nuklejku
demonstration of c. burnetii in a clinical specimen by detection of antigen or nucleic acid.

tagħrif mhux klinikali ma juri l- ebda periklu speċjali għall- bnedmin fuq bażi ta ’ studji ġenerali (ara sezzjoni 4. 6).
non-clinical data reveal no special hazard for humans based on general safety studies (see section 4.6).

dożi ripetuti ta’ dma ipproduċew sinjali ta’ tossiċità fil-fwied, l-ewwel kien hemm żjieda fl-enżimi klinikali tas-serum u wara kien hemm tibdil istopatoloġiku fl-epatoċiti.
repeated doses of dma produced signs of liver toxicity, the first being increases in serum clinical enzymes followed by histopatological changes in the hepatocytes.